These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27147286)

  • 1. Identification of Gene Transcripts Implicated in Peritoneal Membrane Alterations.
    Parikova A; Vlijm A; Brabcova I; de Graaff M; Struijk DG; Viklicky O; Krediet RT
    Perit Dial Int; 2016 11-12; 36(6):606-613. PubMed ID: 27147286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.
    Vlahu CA; Aten J; de Graaff M; van Veen H; Everts V; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2016 11-12; 36(6):614-622. PubMed ID: 27147290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.
    Vrtovsnik F; Coester AM; Lopes-Barreto D; de Waart DR; Van der Wal AC; Struijk DG; Krediet RT; Zweers MM
    Perit Dial Int; 2010; 30(5):558-69. PubMed ID: 20421431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
    Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
    Hong M; Nie Z; Chen Z; Yu X; Bao B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
    Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
    Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-hit approach in the development of an experimental peritoneal sclerosis model.
    Vlijm A; Sampimon DE; de Graaff M; Struijk DG; Krediet RT
    Adv Perit Dial; 2012; 28():26-31. PubMed ID: 23311209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.
    de Graaff M; Zegwaard AH; Zweers MM; Vlijm A; de Waart DR; Vandemaele F; Struijk DG; Krediet RT
    Perit Dial Int; 2010; 30(2):192-200. PubMed ID: 20124192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
    Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
    Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
    de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore.
    Vlijm A; Sampimon DE; de Graaff M; Struijk DG; Krediet RT
    Nephron Exp Nephrol; 2011; 117(1):e1-8. PubMed ID: 20689329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
    PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT signaling is required for peritoneal membrane angiogenesis.
    Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intervention with heparins in a rat model of peritoneal dialysis.
    Schilte MN; Loureiro J; Keuning ED; ter Wee PM; Celie JW; Beelen RH; van den Born J
    Perit Dial Int; 2009; 29(1):26-35. PubMed ID: 19164250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
    Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
    Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
    van Westrhenen R; Aten J; Aberra M; Dragt CA; Deira G; Krediet RT
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S18-21. PubMed ID: 16048249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.